Nuveen Asset Management, LLC Surmodics Inc Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Surmodics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 41,347 shares of SRDX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,347

Previous 42,609 2.96%

Holding current value

$1.28 Million

Previous $1.65 Million 0.91%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$37.5 - $40.13 $47,325 - $50,644	-1,262 Reduced 2.96%	41,347 $1.64 Million
Q1 2024 May 13, 2024	SELL	$27.44 - $35.56 $1.27 Million - $1.65 Million	-46,270 Reduced 52.06%	42,609 $1.25 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $360,458 - $487,321	-12,661 Reduced 12.47%	88,879 $3.23 Million
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $1.26 Million - $1.71 Million	44,470 Added 77.92%	101,540 $3.26 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $222,695 - $394,599	12,603 Added 28.34%	57,070 $1.79 Million
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $7,006 - $15,754	-409 Reduced 0.91%	44,467 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $7,507 - $9,514	255 Added 0.57%	44,876 $1.53 Million
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $10,526 - $14,205	-365 Reduced 0.81%	44,621 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$33.25 - $45.11 $44,821 - $60,808	-1,348 Reduced 2.91%	44,986 $1.68 Million
Q1 2022 May 16, 2022	BUY	$40.68 - $49.72 $20,177 - $24,661	496 Added 1.08%	46,334 $1.96 Million
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $143,543 - $191,347	-3,322 Reduced 6.76%	45,838 $1.98 Million
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $300,432 - $343,220	-5,690 Reduced 10.37%	49,160 $2.87 Million
Q2 2021 Aug 16, 2021	SELL	$51.29 - $59.15 $220,752 - $254,581	-4,304 Reduced 7.28%	54,850 $2.98 Million
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $51,037 - $67,844	1,210 Added 2.09%	59,154 $3.32 Million
Q4 2020 Feb 16, 2021	SELL	$35.18 - $43.52 $134,457 - $166,333	-3,822 Reduced 6.19%	57,944 $2.52 Million
Q3 2020 Nov 16, 2020	SELL	$37.98 - $48.72 $343,187 - $440,233	-9,036 Reduced 12.76%	61,766 $2.4 Million
Q2 2020 Aug 14, 2020	BUY	$31.07 - $44.74 $36,165 - $52,077	1,164 Added 1.67%	70,802 $3.06 Million
Q1 2020 May 14, 2020	SELL	$22.46 - $42.24 $756,452 - $1.42 Million	-33,680 Reduced 32.6%	69,638 $2.32 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $3.19 Million - $3.89 Million	-81,894 Reduced 44.22%	103,318 $4.28 Million
Q3 2019 Nov 14, 2019	BUY	$38.66 - $47.41 $907,504 - $1.11 Million	23,474 Added 14.51%	185,212 $8.47 Million
Q2 2019 Aug 15, 2019	BUY	$38.23 - $47.43 $6.18 Million - $7.67 Million	161,738 New	161,738 $6.98 Million

Others Institutions Holding SRDX

# of Institutions

141

Shares Held

12M

Call Options Held

31.4K

Put Options Held

13.2K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $433M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Surmodics Inc Transaction History